Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2023

01-12-2023 | Oxcarbazepine | Case report

Oxcarbazepine

Lack of efficacy

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
…
Literature
Alexander N, et al. Gait is not Affected by Hemispherotomy-Case Report from Two Children. Neuropediatrics 54: 397-401, No. 6, Jan 2023. Available from: URL: https://dx.doi.org/10.1055/a-2021-0202
Metadata
Title
Oxcarbazepine
Lack of efficacy
Publication date
01-12-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-52115-9

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Lacosamide/Rifaximin

Case report

Crotalidae-immune-Fab-(equine)

Case report

Sugammadex

Case report

Cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamide/vilanterol/fluticasone-furoate interaction

Case report

Cotrimoxazole/methotrexate

Case report

Sertraline